Overview
- Published in the Official Gazette on January 22, Resolución 61/2026 replaces the 2012 regime and governs import, export, manufacture, storage, distribution and sale of non‑vesicular bovine viral vaccines in Argentina.
- The framework admits inactivated and certain live attenuated vaccines for antigens including BoHV‑1 (IBR), BoHV‑5, BVDV, bovine rotavirus, PI3, bovine respiratory syncytial virus and bovine coronavirus.
- Vaccine strains must be circulating in Argentina or show scientifically supported cross‑protection through epidemiological or virological surveillance evidence.
- Controls tighten with required sterility, potency, safety and stability tests, official stamping and a Certificate of Use and Commercialization before sale, plus audit powers, a default one‑year shelf life unless justified, and prior CONABIA clearance for products containing GMOs.
- Separately, Resolución 59/2026 provisionally authorizes cypermethrin, deltamethrin, lambda‑cyhalothrin and diflubenzuron nationwide for locust and tucura control through December 31, 2027, with dimethoate allowed only as bait for Tucura Sapo.